Rights and permissions
About this article
Cite this article
Early initiation of irbesartan provides maximum cost benefits. Pharmacoecon. Outcomes News 460, 5 (2004). https://doi.org/10.2165/00151234-200404600-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404600-00007